MDLinx Nephrology is the one place you can find the most updated medical journal articles that focus on topics such as: kidney function, renal replacement therapy, immunosuppression management, clinical pharmacology, chronic kidney disease and much more. The articles found on MDLinx are thoroughly classified and expertly summarized by our team of medical editors, and then ranked to provide you optimal value for your time.
As a bonus you can check out our “must read” articles highlighted by our physician editor, D. Scott Cunningham, MD, PhD, along with clinical pearls from The Smartest Nephrologist daily quiz competition and review.
Become a member and get exclusive access to Nephrology career opportunities, e-newsletters that keep you updated with the latest medical literature, Category 1 & 2 CME credit opportunities as well as the ability to earn honoraria by participating in Market Research studies.
Your Unread Messages in Nephrology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Clinical Pearls for Nephrologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Moh's surgery in metastatic cancer: renal cell carcinoma solitary cutaneous metastasis and visceral tumor metastases to skin treated with microscopically controlled surgical excision International Journal of Dermatology, May 23, 2013 Clinical Article
2 Active targeted therapy for metastatic collecting duct carcinoma of the kidney: a case report and review of the literature International Urology and Nephrology, May 23, 2013 Review Article
3 Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the international mRCC database consortium criteria Cancer, May 23, 2013 Review Article
4 Severe autoimmune hemolytic anemia with renal neoplasm Pediatric Surgery International, May 21, 2013
5 MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters European Radiology, May 20, 2013 Clinical Article
6 Phase I study of highly selective inhibitor of VEGFR tyrosine kinase, tivozanib, in Japanese patients with solid tumors Cancer Science, May 17, 2013 Review Article
7 CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth The Journal of Urology, May 15, 2013 Clinical Article
8 TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone: Expanding the Morphologic Spectrum American Journal of Surgical Pathology , May 15, 2013 Clinical Article
9 Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma Human Pathology, May 15, 2013 Clinical Article
10 Novel Immunotherapeutic Strategies in Development for Renal Cell Carcinoma Full Text European Urology, May 13, 2013 Review Article
11 Combined diffusion-weighted, blood oxygen level–dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma Academic Radiology, May 13, 2013 Clinical Article
12 Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma Full Text European Urology, May 10, 2013 Clinical Article
13 NF-kB Inhibition by Bortezomib Permits Interferon-γ-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma. Molecular Cancer Therapeutics, May 10, 2013 Clinical Article
14 Reproductive Factors and Kidney Cancer Risk in 2 US Cohort Studies, 1993–2010 American Journal of Epidemiology, May 9, 2013 Clinical Article
15 The Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma Clinical Cancer Research, May 9, 2013 Review Article
16 Kidneys From Donors With Incidental Renal Tumors: Should They Be Considered Acceptable Option for Transplantation Transplantation, May 9, 2013 Review Article
17 Targeted therapies and the treatment of non-clear cell renal cell carcinoma Annals of Oncology, May 8, 2013 Clinical Article
18 Small solid renal masses: Characterization by diffusion-weighted MRI at 3 T Clinical Radiology, May 6, 2013 Clinical Article
19 Bone Morphogenetic Protein-6 in Renal Cell Carcinoma Promotes Tumor Proliferation via M2 Polarization of Tumor-Infiltrating Macrophages through Interleukin-10 Cancer Research, May 3, 2013 Clinical Article
20 Wilms Tumor Presenting With Lambert-Eaton Myasthenic Syndrome Journal of Pediatric Hematology/Oncology, May 3, 2013
As published in the Journal of Infection, patients with community-acquired pneumonia (CAP) and acute cardiac events (ACEs) have a higher fatality rate (19.4%) than patients with CAP but without ACEs (6.4%). Of 3291 patients with CAP over a 15-year period, 315 had ACEs (8%; arrhythmias, n=199; congestive heart failure, n=118; myocardial infarction, n=30). Based on multivariate analysis, chronic heart disease, chronic kidney disease, tachycardia, septic shock, multilobar pneumonia, hypoalbuminemia, and pneumococcal pneumonia were associated with ACEs in patients with CAP.
Read the article summaryResearchers from Martin Luther University Halle-Wittenberg (Germany) have reported that serum amyloid A (SAA) has greater sensitivity in detecting advanced renal tumors than CRP or IL-6 levels. Specifically, the sensitivities and specificities of SAA, CRP, and IL-6 for advanced renal tumors were 78%, 69%, and 44%, and 82%, 82%, and 94%, respectively. Furthermore, the SAA levels were higher in patients with advanced renal tumors than patients with localized renal tumors.
Read the article summaryAs published in the Journal of Pediatrics, NSAID-associated acute tubular necrosis and acute interstitial nephritis occurred in 21 and 6 of 1015 children with acute kidney injuries, respectively. Correct dosing of NSAIDs was confirmed in 75% of the children. Children < 5 years of age had more severe disease, more often requiring dialysis (100% vs. 0) and ICU admission (75% vs. 9%), and increased length of stay (10 d vs. 7 d).
Read the article summary1 Uric Acid Levels Correlate with Baseline Renal Function and High Levels are a Potent Risk Factor for Postoperative Chronic Kidney Disease in Patients with Renal Cell Carcinoma The Journal of Urology, April 15, 2013
2 Is consumption of vegetables and fruit a protective factor against kidney cancer Central European Journal of Medicine, April 22, 2013
3 Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease Cochrane Reviews, April 1, 2013 Review Article
4 Bosniak IIF renal cysts: is there a malignancy potential Journal of Clinical Urology, April 1, 2013
5 Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: a Report by MSKCC and the KIRC TCGA Research Network Clinical Cancer Research, April 26, 2013
6 The tumor suppressive function of UNC5D and its repressed expression in renal cell carcinoma Clinical Cancer Research, April 17, 2013 Review Article
7 Renal Medullary Carcinoma: Molecular, Immunohistochemistry, and Morphologic Correlation American Journal of Surgical Pathology , March 5, 2013
8 Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike Medical Oncology, April 29, 2013
9 Renal Cell Carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion Radiology, April 23, 2013
10 Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells Journal of Natural Medicines, April 8, 2013
11 Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial British Journal of Cancer, April 12, 2013
12 Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort European Journal of Cancer, April 25, 2013
13 Renal cell neoplasm of oncocytosis: a type of unclassified renal cell carcinoma Clinical and Experimental Nephrology Case Reports, April 24, 2013
14 Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine Archives of Pathology & Laboratory Medicine, April 2, 2013 Free full text
15 Sequencing of Agents for Metastatic Renal Cell Carcinoma: Can We Customize Therapy European Urology, January 27, 2012 Free full text
16 Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma The Oncologist, January 30, 2012 Free full text
17 Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy International Urology and Nephrology, January 13, 2012
18 Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma British Journal of Cancer, January 13, 2012
19 Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features Journal of Cancer Research & Clinical Oncology, January 19, 2012
20 T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6 European Urology, January 30, 2012 Free full text
Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantation more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close